Skip to main content
SpringerLink
Log in

Wirkung von SGLT-2-Inhibitoren auf eine gestörte ventrikuläre Repolarisation

Retrospektive Untersuchung bei Patienten mit Typ-2-Diabetes

Effect of SGLT-2 inhibitors on impaired ventricular repolarization

Retrospective study of patients with type 2 diabetes

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ferrannini E, Mark M, Mayoux E (2016) CV protection in the EMPA-REG OUTCOME trial: a „thrifty substrate“ hypothesis. Diabetes Care 39(7):1108–1114

    Article  PubMed  Google Scholar 

  2. Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117–2128

    Article  CAS  PubMed  Google Scholar 

  3. Abdul-Ghani M, Del Prato S, Chilton R, DeFronzo RA (2016) SGLT2 inhibitors and cardiovascular risk: lessons learned from the EMPA-REG OUTCOME study. Diabetes Care 39(5):717–725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mudaliar S, Alloju S, Henry RR (2016) Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis. Diabetes Care 39(7):1115–1122

    Article  CAS  PubMed  Google Scholar 

  5. Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ (2016) SGLT2 inhibition and cardiovascular events: why did EMPA-REG outcomes surprise and what were the likely mechanisms? Diabetologia 59:1333–1339

    Article  PubMed  PubMed Central  Google Scholar 

  6. Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, Welty TK (2000) Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: the Strong Heart Study. Circulation 101(1):61–66

    Article  CAS  PubMed  Google Scholar 

  7. Giunti S, Gruden G, Fornengo P, Barutta F, Amione C, Ghezzo G, Cavallo-Perin P, Bruno G (2012) Increased QT interval dispersion predicts 15-year cardiovascular mortality in type 2 diabetic subjects: the population-based Casale Monferrato Study. Diabetes Care 35(3):581–583

    Article  PubMed  PubMed Central  Google Scholar 

  8. Malik M, Batchvarov VN (2000) Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 36:1749–1766

    Article  CAS  PubMed  Google Scholar 

  9. Veglio M, Chinaglia A, Cavallo-Perin P (2004) QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Invest 27:175–181

    Article  CAS  PubMed  Google Scholar 

  10. Prenner SB, Shah SJ, Goldberger JJ, Sauer AJ (2016) Repolarization heterogeneity: beyond the QT interval. J Am Heart Assoc 5:e3607

    Article  PubMed  PubMed Central  Google Scholar 

  11. Miki T, Tobisawa T, Sato T, Tanno M, Yano T, Akasaka H et al (2014) Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes? Cardiovasc Diabetol 13:125

    Article  PubMed  PubMed Central  Google Scholar 

  12. Klimas J, Kruzliak P, Rabkin SW (2015) Modulation of the QT interval duration in hypertension with antihypertensive treatment. Hypertens Res 38:447–454

    Article  CAS  PubMed  Google Scholar 

  13. Omran J, Firwana B, Koerber S, Bostick B, Alpert MA (2016) Effect of obesity and weight loss on ventricular repolarization: a systematic review and meta-analysis. Obes Rev 17:520–530

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik – Diabetologie, Gemeinschaftskrankenhaus Havelhöhe, Kladower Damm 221, 14089, Berlin, Deutschland

    M. Jecht

Authors
  1. M. Jecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Jecht.

Ethics declarations

Interessenkonflikt

M. Jecht gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jecht, M. Wirkung von SGLT-2-Inhibitoren auf eine gestörte ventrikuläre Repolarisation. Diabetologe 13, 583–585 (2017). https://doi.org/10.1007/s11428-017-0279-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-017-0279-6

Search

Navigation